v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 35,482 $ 20,291
Marketable securities 178,362 115,194
Prepaid expenses and other current assets 10,227 2,588
Total current assets 224,071 138,073
Property and equipment, net 626 701
Operating lease right-of-use asset 99 169
Other assets 1,854 2,909
Total assets 226,650 141,852
Current liabilities:    
Accounts payable 4,589 1,096
Accrued research and development expenses 4,838 6,530
Deferred collaboration revenue—current portion 1,632 0
Other accrued liabilities 6,835 7,815
Total current liabilities 17,894 15,441
Development financing liability 99,248 90,227
Long-term portion of operating lease liability 0 30
Deferred collaboration revenue—non-current portion 1,100 0
Total liabilities 118,242 105,698
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value: 200,000,000 shares authorized; 97,804,712 and 84,681,063 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 17 8
Additional paid-in capital 1,010,958 909,329
Accumulated other comprehensive loss (124) (326)
Accumulated deficit (902,443) (872,857)
Total stockholders' equity 108,408 36,154
Total liabilities and stockholders' equity $ 226,650 $ 141,852

Source

HTML PDF
ZIP